Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)
← catalyst calendarSponsored by Sanofi (industry) · SNY — their whole pipeline →. With Regeneron Pharmaceuticals.
Phase
—
Status
Completed
Study type
Observational
Enrollment
376actual
Sites
41
Countries
Argentina, Chile, Colombia +9
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2020-11-02 | actual | When the study began enrolling |
| Primary completion | 2026-06-18 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-06-18 | actual | The whole study's end, after follow-up |
| First posted | 2020-09-16 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Asthma
Intervention
- Drug: Dupilumab SAR231893 — also filed as Dupixent
Primary outcomes
what the primary-completion date above is the date OFBaseline Characteristics: Socio-demographics
measured At baseline
Baseline Characteristics: Medical history
measured At baseline
Baseline Characteristics: Disease characteristics
measured At baseline
Baseline Characteristics: Biomarkers
measured At baseline
Baseline Characteristics: Concomitant treatments for asthma
measured At baseline
Publications
- PMID 42268495 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · SNY's whole pipeline · Catalyst calendar · Every registered study · What changed